Skip to content

Development of MRI Protocols and Associated Neuro-physiological Explorations in Healthy and Pathological Subjects

Development of MRI Protocols and Associated Neuro-physiological Explorations in Healthy and Pathological Subjects

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05036629
Acronym
MAP-IRMaGE
Enrollment
600
Registered
2021-09-05
Start date
2021-09-09
Completion date
2026-09-08
Last updated
2023-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MRI, Physiological Measurement, Sequence Optimization

Brief summary

IRMaGe is a Joint Service Unit (UMS) which provides users of brain exploration equipment (clinical MRI and preclinical, TMS, EEG, NIRS and metabolomics). The methods available on this equipment are intended to evolve according to the most recent discoveries and this protocol aims to frame the developments necessary around clinical MRI for IRMaGe can continue to offer tools at the cutting edge of technology.

Detailed description

The studies will be carried out on healthy subjects and voluntary patients, who will have given their consent. Their main objective will be the development and optimization of sequence parameters or design stimulation paradigms in order to optimize the quality and relevance of the images produced taking into account the parameters anatomical, functional or metabolic while respecting the experimental constraints imposed by the protocol concerned (equipment of experimentation, additional physiological measurements, etc.). The main judgement criteria will be measurements inherent in the MRI sequence and a physiological measurement associated in the protocol concerned

Interventions

DEVICEMRI Protocol

Eye-tracker Eyelink (eye movements) BIOPAC : (electrodermal resistance) INVIVO Precess : breathing, arterial pressure, pulse, * NIRS Oxymon artinis medical system * tES (transcranial electrical stimulation, Neuroelectrics)

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Exploratory individual statistical analyzes on MRI data functional. No group analysis possible on these updates of MRI protocols

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Participants with normal or corrected vision * Participants affiliated to a social security scheme or beneficiaries of such a scheme * Participants with French as their mother tongue * Participants who have given the signed informed consent before carrying out any procedure related to the study. * Volunteer patients will be recruited as part of their follow-up at the CHU. Their pathology will be in agreement with that of the research protocol to be optimized.

Exclusion criteria

Criteria relating to contraindications to the explorations provided for by the MRI protocol: * metallic glitter in the eyes * retinal operation * claustrophobia * wearer of pacemaker or cardiac defribrillator or vascular clip or prosthesis cardiac or insulin pump or implanted device to deliver medication or hearing implant or prosthesis or vascular shunt or paragraph or screws, plate metal or tattoo or piercing or implanted metal object or lead shot hunt * Alcohol ingestion before the examination * Pregnant, lactating and parturient women * Major protected by law * Participants under administrative or judicial supervision * Participation in another ongoing study if the study may interfere with participation in the protocol MAP-IRMaGe.

Design outcomes

Primary

MeasureTime frameDescription
Diffusion Tensor Imaging Images1 to 3 hoursDTi sequences on IRM Achieva 3.0T dStream Philips
BOLD Signal1 to 3 HoursEPI sequences during cognitive protocol on IRM Achieva 3.0T dStream Philips
Anatomical Images1 to 3 hoursAnatomical MR sequences on IRM Achieva 3.0T dStream Philips

Secondary

MeasureTime frameDescription
Near-infrared spectroscopy (NIRS) : Hb OHb concentration measurementDuring MRI sessionAcquired with NIRS Oxymon artinis medical system
Eye movementsDuring MRI sessionAcquired by using eye-tracker (Eye-tracker Eyelink) breathing arteries pressure electrodermal conductance
tESDuring MRI sessionTranscranial Electrical stimulation, Neuroelectrics
Electrodermal resistanceDuring MRI sessionAcquired on BIOPAC device allowing physiological measurements
Blood Pressure/pulse/BreathingDuring MRI sessionAcquired on INVIVO Precess

Countries

France

Contacts

Primary ContactATTYE ARNAUD, MD, PhD
aattye@chu-grenoble-alpes.fr4 76 76 57 39
Backup ContactCOUSIN EMILIE, PhD
emilie.cousin@univ-grenoble-alpes.fr0613638645

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026